The 2025 American Society of Clinical Oncology (ASCO) Conference in Chicago brought together the industry’s biggest leaders, innovators, and decision-makers to address the rapidly evolving landscape of oncology therapies. This year’s theme, Driving Knowledge to Action: Building a Better Future,was about turning cutting-edge science into real-world impact for patients. Our Nexus leadership team was on the ground, engaging in thoughtful conversations and gathering insights into this ever-changing space. Here are a few standout moments that caught our attention: 

AI is everywhere: AI continues to dominate the conversation across the spring conference season, and ASCO was no exception. ASCO President Robin Zon announced a collaboration with Google Cloud to launch the ASCO Guidelines Assistant, powered by Gemini AI. This new program is designed to help oncologists access clinical guidelines faster and more intuitively, providing big potential for streamlining care. 

Precision oncology is getting even sharper: Biomarker-driven therapies and personalized treatment strategies were at the forefront of many conversations and panels. Several trials showed how genomic profiling is helping tailor treatments more effectively across a range of cancers. 

Immunotherapy keeps evolving: Newly announced trial data reinforced the growing role of immunotherapy, especially in combo regimens for cancers like bladder, head and neck, and lung. The survival gains are real and promising. 

Equity in cancer care: There was a big focus on reducing disparities in treatment. Many sessions highlighted ways to expand access to clinical trials, improve care in underserved areas, and build global partnerships to make treatment more equitable. 

The oncology space is rapidly evolving, and so are the conversations around how we ensure innovative therapies reach the right patients in the right settings at the right time. This year’s ASCO conference not only highlighted scientific breakthroughs but also the growing urgency to align clinical innovation with real-world access strategies. 

About Nexus Health

The Nexus Health Group provides an integrated, simplified approach to comprehensive market access strategies, offering solutions in strategic
consulting, value communications, and patient access and affordability. Nexus experts combine deep market access experience in complex therapies with a foundation in science to provide the strategic advantages manufacturers need to launch and differentiate their products in today’s marketplace. Launched in 2025, Nexus may be a new company, but with an average of 21+ years of experience, the team is far from new to market access.

About the Author

RYAN COX, RPh, MBA
Ryan’s insider knowledge as a former payer and more than 30 years of experience set him apart in the industry. Clients value his unique, real-world perspective on market access strategy, messaging, pull-through, and label expansions and rely on his formulary management, risk-based contracting, and deep therapeutic experience to meet access goals while optimizing utilization and reimbursement.